Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 6/20 | 0.54 |
| ▸ | KDM5B | Q9UGL1 | 5/20 | 0.54 |
| ▸ | KDM6B | O15054 | 4/20 | 0.54 |
| ▸ | KDM4A | O75164 | 4/20 | 0.54 |
| ▸ | KDM4D | Q6B0I6 | 4/20 | 0.54 |
| ▸ | HIF1AN | Q9NWT6 | 4/20 | 0.54 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.54 |
| ▸ | KDM3B | Q7LBC6 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | KDM5A | P29375 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | BRS3 | P32247 | 2/20 | 0.46 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3912930 | 0.85 | KDM4E (0.53) | DAOKDM5BKDM6BKDM4AKDM4D | |
| SCHEMBL4429436 | 0.83 | KDM4E (0.53) | DAOKDM5BKDM6BKDM4AKDM4D | |
| SCHEMBL4428237 | 0.82 | KDM4E (0.50) | DAOKDM5BKDM6BKDM4AKDM4D | |
| SCHEMBL8326795 | 0.80 | HTR1A (0.54) | KDM5BKDM6BKDM4AKDM4DHIF1AN | |
| SCHEMBL4430955 | 0.80 | KDM4E (0.47) | KDM5BKDM6BKDM4AKDM4DHIF1AN | |
| SCHEMBL4432530 | 0.80 | KDM4E (0.47) | DAOKDM5BKDM6BKDM4AKDM4D | |
| SCHEMBL4432424 | 0.78 | HNF4A (0.49) | DAOKDM5BKDM6BKDM4AKDM4D | |
| SCHEMBL1150021 | 0.77 | GPR84 (0.47) | DAOKDM5BKDM5AGPR84BRS3 | |
| Benzylphenylether SCHEMBL8328497 | 0.77 | NR4A2 (0.46) | KDM5BKDM6BKDM4AKDM4DHIF1AN | |
| SCHEMBL9339112 | 0.77 | MAPT (0.49) | DAOKDM5BKDM6BKDM4AKDM4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3353162-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | Glaxosmithkline Intellectual Property (No. 2) Limited (GB) | 2018-08-01 | — | — | EP | disclosed |
| EP-3344615-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GlaxoSmithKline Intellectual Property (No. 2) Limited (GB) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017060180-A1 | 2-OXO-1,2-DIHYDROPYRIDINE-3,5-DICARBOXAMIDE COMPOUNDS AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2017-04-13 | — | — | WO | disclosed |
| WO-2017050714-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2017-03-30 | — | — | WO | disclosed |
| WO-2017037116-A1 | PYRIDINONE DICARBOXAMIDE FOR USE AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2017-03-09 | — | — | WO | disclosed |
| EP-2125739-A1 | MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008079371-A1 | MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| EP-0509769-B1 | Heterocyclic amides having HLE inhibiting activity | ZENECA LTD (GB) | 1996-09-11 | — | — | EP | disclosed |
| US-5521179-A | Heterocyclic amides | ZENECA LIMITED (GB) | 1996-05-28 | — | — | US | disclosed |
| EP-0509769-A2 | Heterocyclic amides having HLE inhibiting activity | ZENECA LIMITED (GB) | 1992-10-21 | — | — | EP | disclosed |
| US-3948903-A | Substituted N-(1,2-dihydro-2-oxonicotinyl)-cephalexins and -cephaloglycins | PARKE, DAVIS & COMPANY (US) | 1976-04-06 | — | — | US | disclosed |